Related references
Note: Only part of the references are listed.Downregulation of FOXO3a by DNMT1 promotes breast cancer stem cell properties and tumorigenesis
Hao Liu et al.
CELL DEATH AND DIFFERENTIATION (2020)
Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2
Jun Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
FOXO3a knockdown promotes radioresistance in nasopharyngeal carcinoma by inducing epithelial-mesenchymal transition and the Wnt/β-catenin signaling pathway
Min Luo et al.
CANCER LETTERS (2019)
Breast cancer
Nadia Harbeck et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
FOXO Transcription Factors Both Suppress and Support Breast Cancer Progression
Marten Hornsveld et al.
CANCER RESEARCH (2018)
Vascular endothelial growth factor signaling in development and disease
Sinem Karaman et al.
DEVELOPMENT (2018)
Forkhead box O proteins: Crucial regulators of cancer EMT
Zhiqiang Ma et al.
SEMINARS IN CANCER BIOLOGY (2018)
miR-338-3p functions as a tumor suppressor in gastric cancer by targeting PTP1B
Feng Sun et al.
CELL DEATH & DISEASE (2018)
Epithelial-mesenchymal transition in tumor metastasis
Kay T. Yeung et al.
MOLECULAR ONCOLOGY (2017)
VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-kappa B and beta-catenin
Minna Luo et al.
CANCER LETTERS (2016)
Impact of the physical microenvironment on tumor progression and metastasis
Fabian Spill et al.
CURRENT OPINION IN BIOTECHNOLOGY (2016)
The role of MicroRNAs in human cancer
Yong Peng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2016)
FOXO3a modulates WNT/beta-catenin signaling and suppresses epithelial-to-mesenchymal transition in prostate cancer cells
Hao Liu et al.
CELLULAR SIGNALLING (2015)
MicroRNA-338-3p functions as tumor suppressor in breast cancer by targeting SOX4
Ying Jin et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia- inducible factor-1α in ERK-responsive lung cancer
Chun-Wen Cheng et al.
ONCOTARGET (2015)
AMPK Reverses the Mesenchymal Phenotype of Cancer Cells by Targeting the Akt-MDM2-Foxo3a Signaling Axis
Chih-Chien Chou et al.
CANCER RESEARCH (2014)
Downregulation of FOXO3a Promotes Tumor Metastasis and Is Associated with Metastasis-Free Survival of Patients with Clear Cell Renal Cell Carcinoma
Dong Ni et al.
CLINICAL CANCER RESEARCH (2014)
GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression
Jonathan Chou et al.
NATURE CELL BIOLOGY (2013)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail et al.
NATURE MEDICINE (2013)
Dual Inactivation of Akt and ERK by TIC10 Signals Foxo3a Nuclear Translocation, TRAIL Gene Induction, and Potent Antitumor Effects
Joshua E. Allen et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Forkhead box proteins: tuning forks for transcriptional harmony
Eric W. -F. Lam et al.
NATURE REVIEWS CANCER (2013)
Neuropilin-1 expression in cancer and development
Adrian M. Jubb et al.
JOURNAL OF PATHOLOGY (2012)
miRNA-29b Suppresses Prostate Cancer Metastasis by Regulating Epithelial-Mesenchymal Transition Signaling
Peng Ru et al.
MOLECULAR CANCER THERAPEUTICS (2012)
β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer
Stephan P. Tenbaum et al.
NATURE MEDICINE (2012)
FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer
C. T. Karadedou et al.
ONCOGENE (2012)
VEGF binding to NRP1 is essential for VEGF stimulation of endothelial cell migration, complex formation between NRP1 and VEGFR2, and signaling via FAK Tyr407 phosphorylation
Birger Herzog et al.
MOLECULAR BIOLOGY OF THE CELL (2011)
VEGF and angiopoietin signaling in tumor angiogenesis and metastasis
Pipsa Saharinen et al.
TRENDS IN MOLECULAR MEDICINE (2011)
Foxo3a Suppression of Urothelial Cancer Invasiveness through Twist1, Y- Box- Binding Protein 1, and E-Cadherin Regulation
Masaki Shiota et al.
CLINICAL CANCER RESEARCH (2010)
Foxo3a Regulates Apoptosis by Negatively Targeting miR-21
Kun Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Breast Cancer Metastasis: Challenges and Opportunities
J. Lu et al.
CANCER RESEARCH (2009)
A New Fork for Clinical Application: Targeting Forkhead Transcription Factors in Cancer
Jer-Yen Yang et al.
CLINICAL CANCER RESEARCH (2009)
FOXO3a Promotes Tumor Cell Invasion through the Induction of Matrix Metalloproteinases
Peter Storz et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEM-2, neuropilin-1) are associated with worse outcome in breast cancer
Sriparna Ghosh et al.
HUMAN PATHOLOGY (2008)
Metastasis suppressors genes in cancer
Lewis J. Stafford et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation
Jer-Yen Yang et al.
NATURE CELL BIOLOGY (2008)
Breast cancer metastasis: Markers and models
B Weigelt et al.
NATURE REVIEWS CANCER (2005)
Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer
H Bando et al.
BRITISH JOURNAL OF CANCER (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Vascular endothelial growth factor: Basic science and clinical progress
N Ferrara
ENDOCRINE REVIEWS (2004)
FoxO3a transcriptional regulation of bim controls apoptosis in paclitaxel-treated breast cancer cell lines
A Sunters et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Share Paper
